On 3 April 2024, the Company announced publication of the results of the RED DESERT and SAHARA proof-of-concept studies, in the prestigious peer-reviewed journal European Journal of Heart Failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results